Sciety flags revived US biotech IPO market as 20 listings raise $6.1 billion in 2026
Sciety said 20 US drug-development biotech IPOs priced through mid-August 2026, including six Nasdaq biopharma deals over summer that upsized.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.